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Abstract: Due to the limited success rate of currently available
vascular replacements, tissue engineering has received tre-
mendous attention in recent years. A main challenge in the
field of regenerative medicine is creating a mechanically func-
tional tissue with a well-organized extracellular matrix, particu-
larly of collagen and elastin. In this study, the native collagen
scaffold derived from decellularized tendon sections, as a scaf-
fold having the potential to be used for vascular tissue engi-
neering applications, was studied. We showed that the
elasticity of the scaffolds was improved when crosslinked with
the bovine elastin. The effect of different concentrations of
elastin on mechanical properties of the collagen scaffolds was
evaluated of which 15% elastin concentration was selected for
further analysis based on the results. Addition of 15% elastin
to collagen scaffolds significantly decreased Young’s modulus
and the tensile stress at the maximum load and increased the
tensile strain at the maximum load of the constructs as com-
pared to those of the collagen scaffolds or control samples.
Moreover, tubular elastin modified collagen scaffolds showed
significantly higher burst pressure compared to the control
samples. Smooth muscle cells and endothelial cells cultured
on the elastin modified collagen scaffolds showed high viabil-
ity (>80%) after 1, 3, and 7 days. Furthermore, the cells showed
a high tendency to align with the collagen fibers within the
scaffold and produced their own extracellular matrix over time.
In conclusion, the results show that the decellularized tendon
sections have a great potential to be used as scaffolds for vas-
cular tissue engineering applications. © 2019 Wiley Periodicals,
Inc. J Biomed Mater Res Part A: 107A: 1225–1234, 2019.
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INTRODUCTION
Vascular diseases are a leading cause of death in the world.1
Many surgeries are performed every year in order to replace
a diseased vessel with a vascular graft. Coronary, cerebral,
and peripheral arteries are commonly diseased vessels.2 Syn-
thetic grafts, such as polytetrafluoroethylene (PTFE), are
often used as large diameter vascular replacements.3 How-
ever, they do not perform well when used for small diameter
replacements (<6 mm) as they are prone to infection, throm-
bus formation, or intimal hyperplasia, which finally results
in occlusion and failure of the grafts.3,4 Autologous vessels,
such as saphenous veins, are currently used instead, but not
all patients have a healthy vessel suitable for use.5
Tissue-engineered vascular grafts, having the ability to
remodel and grow, are currently studied as promising alter-
natives for vascular graft replacements.3,5 Under physiologi-
cal pulsatile blood pressure of 80–120 mmHg, the vessel
wall is subjected to the circumferential stresses and strains
of 100–150 kPa and 10%–15%, respectively.6 The main
dilemma in vascular tissue engineering is that the engi-
neered grafts are not mechanically robust enough to with-
stand in vivo hemodynamic forces and do not possess elastic
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properties.7 The presence of a well-organized extracellular
matrix (ECM), especially one containing collagen and elastin
components, is shown to be essential in providing mechani-
cal strength and compliance and maintaining long-term
functionality.
Mechanical properties and structure of blood vessels vary
depending on their anatomical location and function.8 For
example, in terms of the mechanical stiffness, Young’s modu-
lus of 16.7 and 700 kPa was reported for human coronary
arteries and porcine carotid arteries, respectively.9 In general,
collagen is the major reinforcing ECM component in the vessel
wall, and its anisotropic structural arrangement results in
mechanical strength of the wall.10 Elastin is another essential
element of the ECM providing elasticity to the vascular wall.11
In tissue-engineered blood vessels, scaffolds have been used
to provide initial mechanical properties to the growing tissue.
Moreover, they have been used as a template for the cells to
synthesize their ECM in a desired direction, preferably identi-
cal to their native counterparts. Since topological features pro-
vided by the scaffold direct the orientation of both the cells
and the synthesized ECM, it is important to use a scaffold with
appropriate alignment to produce constructs with initial
native-like anisotropic structure.12–14
For vascular tissue engineering applications, the scaffold
should be biodegradable, biocompatible, possess native-like
anisotropic mechanical properties and structure and be pro-
ducible in a tubular configuration. The structure and proper-
ties of a scaffold are influenced by the material and
production procedure. Due to low antigenic and inflammatory
properties of collagen, as a biodegradable natural polymer, it
could represent a potential material for vascular tissue
engineering.15–17 In order to create topological features on
collagen scaffolds, methods such as electrospinning.18 and
micropatterning19 can be applied. However, it is not possible
to maintain the native triple helix structure and properties of
the collagen through these fabrication techniques. We recently
developed a technique to fabricate collagen scaffolds from
decellularized tendon, which keeps the native structure of col-
lagen fibers and allows us to produce tubular constructs.20,21
By applying our scaffold fabrication technique on tendon-
derived collagen, both flat and tubular constructs can be pro-
duced while the native triple helix structure of collagen fibers
and the proteoglycan content is maintained.22,23 This means
that the scaffold can provide both anisotropic mechanical
strength and contact guidance cues due to its natural topo-
graphical features, besides providing a natural substrate for
cells to interact with. It was shown in a previous study that
anisotropic mechanical properties of the scaffold could be
manipulated by either adding a crosslinking agent or changing
the orientation of the stacked tendon slices.20 It should be
also noted that depending on the structure of the native target
vessel tissue, the alignment and number of stacked slices
could be altered. Since elastin is not vastly present in tendon
tissues and elasticity is an essential property of native vascu-
lar tissues, these collagen scaffolds need to be optimized in
this regard by addition of an elastic component.
The aim of the current study was to evaluate the feasibil-
ity of using tendon-derived collagen scaffolds for vascular
FIGURE 1. (A) Schematic drawing of scaffold fabrication. Decellularized tendon blocks (1) were sectioned into 50 μm slices (2). To make sheets,
three slices were stacked on top of each other. However, to make tubes, 10 slices were stacked with alternating fiber orientation and rolled around
a Teflon rod (3). (B) Reaction scheme for the crosslinking of collagen with butyraldehyde. The crosslinking mechanism is based on imine formation
between amino groups in collagen and aldehyde functions from glutaraldehyde.
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tissue engineering applications. First, the effect of different
concentrations of elastin on the mechanical properties of the
scaffolds was studied and the optimum concentration was
chosen. Physical characteristics of collagen scaffolds were
analyzed by measuring the swelling ratio and via scanning
electron microscopy (SEM) measurements. Furthermore, the
burst pressure was measured on tubular scaffolds. The via-
bility and alignment of cells cultured on scaffold sheets were
also analyzed. Lastly, the mechanical properties and the
amount of hydroxyproline as a measure of collagen pro-




Frozen bovine Achilles tendon was sliced into blocks of ~20
× 20 × 2 mm using a cryomicrotome (CM1950, Leica Micro-
systems, Buffalo Grove, IL). The slices were placed into a
decellularization solution (1% w/v sodium dodecyl sulfate
(SDS) (Sigma, St. Louis, MO), 1 mM Tris-HCl, 0.1 mM EDTA
(Tris-EDTA pH 7.4, Sigma) in phosphate buffered saline
(PBS)) shaking for 48 h at 4C. The solution was changed
after 24 h. In order to remove residual SDS, the blocks were
then rinsed in deionized water (diH2O) for 24 h. The blocks
were sectioned at 50 μm thick. As shown in Figure 1(A),
individual sheets were produced by placing a section on a
PTFE block, while tubular conduits were created by rolling
individual 50 μm sections around PTFE rods, 3.175 mm in
diameter. An initial section was placed on the rod with fibers
oriented parallel to the axis of the rod; subsequent sections
were alternated by 90 creating axial and circumferential
orientations. The sections were allowed to dry on the rod,
rehydrated and rinsed in three changes of diH2O. In order to
increase the extensibility of the scaffold, stacks of three indi-
vidual sheets having the fibers aligned as well as the tubular
scaffolds were soaked in the indicated concentration (10%,
15%, and 20%) of elastin from bovine neck ligament
(Sigma) containing 0.1% of glutaraldehyde (GA) for cross-
linking [Fig. 1(B)]. The soaked sheets and tubes were placed
on ice for 3 h to let the elastin diffuse within the sheets prior
to complete crosslinking. Crosslinked elastin samples with-
out the presence of collagen scaffold were mechanically
weak, and non-crosslinked collagen sheets were difficult to
handle without any damage and thus excluded from further
analysis. Samples without elastin were crosslinked by
immersion in 0.1% of GA for 20 min. All samples were then
washed three times in diH2O. A group of scaffolds was ana-
lyzed in terms of mechanical properties, swelling ratio and
structure before seeding the cells. Three samples per group
were included in each analysis.
Cell culture
Human smooth muscle cells (SMCs) and endothelial cells
(ECs) were obtained from Lonza (Walkersville, MD), and
were cultured in SMCs and ECs growth medium (Lonza),
respectively, containing 10% fetal bovine serum. The scaf-
fold sheets were seeded with either SMCs or ECs from pas-
sage 5. The scaffolds were sterilized in 70% ethanol before
cell seeding and then washed in PBS. Subsequently, the
scaffolds were placed in tissue engineering medium (cell cul-
ture medium supplemented with L-ascorbic acid 2-phosphate
[0.25 mg/mL, Sigma, USA]) for 24 h to enhance cell attach-
ment.24 Then, the scaffolds were placed in the PDMS rectan-
gular wells to avoid the cells from attaching to the wells, and
were seeded with cells with a density of 3 million per cm3.
The tissue engineering medium was replaced twice per week.
To analyze the cell viability and cell orientation, the samples
were cultured for 1, 3, and 7 days. Moreover, to evaluate the
mechanical properties and hydroxyproline amount, as a mea-
sure of collagen production, the constructs were cultured for
1, 2, and 3 weeks. The tubular constructs were also cultured
for 3 weeks. All analyses were performed on 3 individual
samples per group per time point.
Mechanical characterization
Uniaxial tensile testing of the samples was performed using a
mechanical tester (Instron, Norwood, MA) at a strain rate of
1 mm/min with a 10 N load cell. The dimension of the sam-
ples was measured with a digital caliper before each test. Ten-
sile stress and strain at the maximum load and the elastic
modulus calculated from the second linear region of the
stress–strain curve were determined. The elastic modulus
was calculated via linear regression of the slope of the curve.
Scanning electron microscopy
Samples were lyophilized and placed on aluminium pin
mounts. All samples were sputter-coated with gold prior to
imaging and imaged with XL20 (FEI Company). Collagen
sheets and 15% elastin modified sheets were imaged.
Swelling ratio
The swelling behavior of collagen sheets and 15% elastin
modified sheets were determined in PBS at 37C as previ-
ously described.25 In short, samples were lyophilized and
their weights were measured. After 24 h incubation in PBS,
the samples were removed from PBS and reweighted. The
swelling ratio was calculated based on the following equa-
tion: (Wwet–Wdry)/Wdry × 100%, in which Wdry is the
weight of the sample after lyophilizing and Wwet is after
removal of the sample from PBS.
Burst pressure measurement
Burst pressure was calculated from the tubular conduits
using an in-house built device based on designs modified
from Gray et al.26 A syringe pump (NE-1000, New Era Pump
Systems Inc., Farmingdale, NY) was used to generate pres-
sure, which was measured using a gage pressure transducer
with a 0–100 Psi range (PX26-100GV, Omega, Stamford, CT)
coupled to a voltage meter (DP25B-S, Omega) and the sam-
ple diameter was recorded using a Sony α6000 camera with
a SEL30M35 30 mm F3.5 macro lens (Sony). Tubular sam-
ples were mounted to dispensing needles using epoxy. The
epoxy was allowed to cure for 1 h and the samples rehy-
drated using diH2O. The syringe pump was set to a flow rate
of 1 mL/min or 10 mL/min, the system cleared of air, and
the exit flow shut off, increasing pressure in the system.
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The samples were tested until failure while being imaged.
Frames of the initial and final diameter were extracted from
video recordings of the tested tubes. The diameter was cal-
culated using Image J (NIH, Bethesda, ML).
Cell viability
Cell viability was assessed using a Live/Dead viability assay
kit (Invitrogen, USA) following instruction from the manufac-
turer at day 1, 3, and 7. Fluorescence images were taken
using an inverted fluorescence microscope (Nikon TE 2000-U,
Nikon instruments Inc., USA). Image J was used to count the
live and dead cells. Cell viability was calculated by dividing
the number of live cells by the total number of stained cells.
Cell alignment
Tissues were fixed using 4% formaldehyde after culturing. They
were permeabilized for 30 min in 0.5% Triton-X in PBS, and
were incubated with FITC-conjugated phalloidin (1:100, Sigma)
for 30 min at room temperature. The images were taken using
an inverted fluorescence microscope (Nikon TE 2000-U, Nikon
instruments Inc., USA). To evaluate the local fiber orientation,
an Image J plug-in called Orientation J was used.27
Total collagen analysis
To determine the amount of hydroxyproline, as a measure of
collagen amount, a modified protocol developed by Huszar
et al. was used.28 Samples were digested in papain solution
(11 mM phosphate buffer, pH = 6.5, 5 mM L-cysteine, 5 mM
EDTA, and 125–140 μg papain per ml) for 16 h. Standard
curves were obtained from trans-4-hydroxyproline (Sigma).
The collagen amount is shown as μg per mg dry weight.
Statistical analysis
Mechanical characteristics, cell viability and collagen content
data are presented as mean  standard error of mean. One-
way ANOVA, followed by Tukey’s multiple comparison post
hoc test, was used to determine the difference between dif-
ferent time points. Furthermore, to test the statistical differ-
ences between samples with/without elastin crosslinking or
with/without cell seeding in time, two-way ANOVA was per-
formed. GraphPad Prism software (GraphPad Software, Inc.)
was used to perform statistical analysis. A p value <0.05 was
considered significant. Finally, observed power was calcu-
lated using SPSS (IBM Corp, NY).
FIGURE 2. Young’s modulus (A), tensile strain at the maximum load (B), tensile stress at the maximum load (C), and representative tensile stress–
strain curves (D) of collagen sheets crosslinked with different elastin concentrations (0% (control), 10%, 15%, and 20%). Young’s modulus was sig-
nificantly lower and tensile strain at the maximum load was significantly higher in samples crosslinked with 15% elastin compared to the control
and 10% elastin modified samples (A,B). Moreover, the tensile stress was significantly lower in 15% elastin modified samples compared to the con-
trol group (C). Observed power for A, B, and C was 1. (*p < 0.05, **p < 0.01, ***p < 0.001).
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RESULTS
Physical characterization
Young’s modulus, tensile strain at the maximum load and
tensile stress at the maximum load were significantly influ-
enced by crosslinking the collagen sheets with elastin
(Fig. 2). Young’s modulus of the control and 10% elastin
modified collagen sheets were significantly higher than 15%
and 20% elastin modified sheets. While, there was no signifi-
cant difference between 15% and 20% elastin modified
sheets [Fig. 2(A)]. Furthermore, tensile strain at the maxi-
mum load of 15% elastin modified sheets was significantly
higher than the control and 10% elastin modified samples.
Again, there was no significant difference between 15% and
20% elastin modified sheets [Fig. 2(B)]. On the other hand,
there was no significant difference between tensile stress at
the maximum load of 10%, 15%, and 20% elastin modified
sheets, while they were all significantly lower than the con-
trol [Fig. 2(C)]. Representative tensile stress versus strain
curves showed that by crosslinking the sheets with 15%
elastin, the extensibility of the scaffold was tremendously
increased [Fig. 2(D)]. Based on the mechanical properties
data, collagen sheets crosslinked with 15% elastin had been
selected for further investigations.
The swelling ratio of 15% elastin modified sheets was
significantly higher as compared to the control [Fig. 3(A)].
The SEM images demonstrated that the natural wavy struc-
ture of collagen fibers was preserved during the scaffold
preparation [Fig. 3(B)] and elastin solution homogeneously
diffused into the collagen fibers [Fig. 3(C)]. The burst pres-
sure in elastin modified collagen tubes was significantly
higher as compared to non-modified collagen tubes when
both 1 mL/min and 10 mL/min flow rates were applied
[Fig. 4(A,B)]. There was no significant difference between
SMCs seeded collagen tubes and elastin modified or non-
modified collagen tubes [Fig. 4(A)]. The representative image
of elastin modified collagen tubes clearly shows the tremen-
dous inflation of the tubes after a defined flow rate was
applied [Fig. 4(C)]. Finally, it should be mentioned that the
inner and outer diameters of the SMCs seeded collagen tubes
after 3 weeks of culture were not significantly different than
those of the control group (data not shown).
Cell-material interaction
Live/Dead viability assay revealed that both spindle-shaped
SMCs [Fig. 5(A)] and cobblestone-shaped ECs [Fig. 5(B)]
could attach and grow on the collagen sheets, suggesting
their biocompatibility. Both cell types cultured on the colla-
gen sheets for 1, 3, and 7 days showed the cell viability of
over 80% [Fig. 5(C)]. The cell viability of both SMCs and ECs
was significantly increased after 7 days as compared to the
first day. Cell orientation distribution revealed that both
SMCs [Fig. 6(A)] and ECs [Fig. 6(B)] stayed aligned with the
collagen fibers of the sheets on which they are cultured after
1, 3, and 7 days (Fig. 6).
Mechanical properties and collagen production in vitro
There was no significant difference between Young’s modu-
lus of SMCs seeded and cell-free control collagen sheets as
well as SMCs seeded and cell-free elastin modified collagen
FIGURE 3. Swelling properties (A) and representative SEM images (B,C) of non-modified and 15% elastin modified collagen sheets. The swelling
ratio was significantly elevated when collagen sheets were modified with 15% elastin with the observed power equal to 1 (A). Further, SEM images
revealed anisotropic alignment of collagen fibers (B,C).
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sheets with time. However, Young’s modulus of non-
modified collagen sheets was significantly higher than both
seeded and cell-free elastin modified sheets at all time points
[Fig. 7(A)]. As shown in Figure 7(B), tensile strain at the
maximum load of both seeded and cell-free collagen sheets
was significantly lower than seeded and cell-free elastin
modified sheets after 1 week. However, this value was signif-
icantly lower only in SMCs seeded collagen sheets as com-
pared to both seeded and cell-free elastin modified sheets at
week 2. Furthermore, there was no significant difference
between all four groups after 3 weeks. The collagen amount
was significantly higher in SMCs seeded collagen sheets as
compared to cell-free collagen sheets after 2 and 3 weeks of
culture [Fig. 7(C)].
DISCUSSION
The aim of this study was to evaluate the feasibility of using
decellularized tendon-derived scaffolds as a natural sub-
strate for vascular tissue engineering applications. It has
been known that a functional vascular graft should have ten-
sile strength to provide mechanical stability, elasticity to pro-
vide rebound and avoid aneurysm development, and a
confluent endothelial layer to avoid thrombogenic and
immunogenic complications. Since the mechanical properties
of tissue engineered vascular grafts are determined by the
properties of the scaffold before the developing tissue pro-
duces its own matrix, it is important that the scaffold can
provide appropriate physical and mechanical properties at
the early stages of tissue development. Collagen has been
shown to be an appropriate material in many biomedical
applications;29,30 for instance, decellularized tendon-derived
scaffold was shown to be a suitable substrate for nerve
regeneration in both in vitro and in vivo studies.31,32 In this
study, we evaluated the feasibility of using decellularized
tendon-derived scaffolds for vascular regeneration applica-
tions. Since elasticity is essential for these applications,33 the
scaffolds were crosslinked with the bovine elastin to add an
elastic component to the constructs.
It was shown previously that the architecture, mechani-
cal properties and thickness of the vessel wall vary with
respect to their anatomical location and age. These charac-
teristics are defined by the physical stresses applied to the
vessel wall by pressure and blood flow.34–36 Due to aniso-
tropic mechanical properties and fibrous arrangement of the
decellularized tendon-derived scaffold, we can create con-
structs with different thicknesses and alignments resembling
those of the target vessel walls. Desired anisotropic mechani-
cal properties can be reached by stacking sections in differ-
ent directions and crosslinking the sheets with other natural
materials such as elastin. In this study, we showed that by
adding the bovine elastin to the scaffolds, the extensibility
FIGURE 4. The burst pressure of non-modified, modified and SMCs seeded collagen tubes at a rate of 1 mL/min (A), non-modified and elastin-
modified collagen tubes at a rate of 10 mL/min (B), and representative images of elastin modified tubes before and after the burst pressure mea-
surement (C). Elastin modified tubes had significantly higher burst pressure at both rates compared to non-modified collagen tubes. Further, the
burst pressure of SMCs seeded collagen tubes was not significantly different from unseeded and elastin modified collagen tubes. Observed power
for A was 0.63 and for B was 0.93.
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and Young’s modulus of the scaffolds were significantly
changed. We also showed in a previous study that the addi-
tion of glutaraldehyde improved the strength of the scaffolds
significantly.37 Moreover, reduction of the scaffold modulus
by addition of elastin was also shown in previous studies.9,38
However, it is not clear yet what mechanisms are involved
in the reduction of the modulus, and should be explored in
the future studies. Therefore, depending on the target vessel,
constructs with different structures and mechanical proper-
ties can be created.
Conclusions from the mechanical properties and burst
pressure measurements should be drawn carefully due to the
limitations of the study. First, it should be mentioned that the
thickness of the samples was measured using a digital caliper.
This might result in undermeasurement of the dimensions as
the samples can be squeezed during the measurements, which
potentially can affect the mechanical properties results. Next,
it is also important to evaluate the viscoelastic behavior of the
constructs by stress-relaxation and by cyclic loading hystere-
sis analysis in the future studies.
Moreover, the infusion rate of 1 and 10 mL/min were
selected for burst pressure measurements based on a range
obtained from previous studies.39–44 However, in another
study, a higher infusion rate up to 100 mL/min was
applied.43 In this case, the leakage through the weak parts of
the graft was avoided by application of a non-porous inner
lining sleeve, which might finally lead to overestimation of
the graft burst pressure.43 We also observed that sweating
of the constructs was higher on collagen scaffolds which had
bigger pores compared to the elastin-modified group as
shown in the SEM images. This could be one of the reasons
behind a faster burst and thus lower burst pressure in colla-
gen tubes compared to the elastin-modified ones. Finally, in
many studies, the infusion rate is not specified.45–49
There are no precise guidelines regarding the burst pres-
sure measurements, which has led to a considerable
FIGURE 5. Representative images of live/dead assay of SMCs and ECs seeded on aligned collagen sheets at day 1, day 3, and day 7 of culture. Both
SMCs (A) and ECs (B) seeded sheets became more confluent with time. Live cells are shown in green and dead cells in red. Scale bars represent
100 μm (C). Cell viability for both SMCs and ECs increased significantly after 7 days (observed power for SMCs was 0.94 and for ECs was 0.99).
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variation of methods and parameters used in previous stud-
ies.43 Moreover, interaction of blood with the vessel wall is
different than that of water as blood leaves a thin layer of
clot on the luminal side of the grafts which ultimately seals
the pores. Therefore, it is challenging to design a set-up
which exactly mimics the parameters that are applied in an
in vivo environment.
Another important issue when using a potential scaffold
for a particular application is to look into the in vitro bio-
compatibility of the material. Parameters such as viability,
proliferation, and attachment of cells are important in this
regard. In this study, both SMCs and ECs showed a high rate
of viability when cultured on collagen sheets. The cells
formed almost a confluent layer after 7 days and aligned
with the collagen fibers in the scaffold. Formation of a con-
fluent layer of cells is important, especially when it comes to
the functionality of the ECs as they are meant to avoid devel-
opment of thrombogenic and immunogenic complications.34
Moreover, it is essential to guide the alignment of the
SMCs and consequently the ECM they produce to provide
tissue engineered constructs with desired burst strength,
compliance, and stability, preferably similar to their native
counterparts.34–36 The results showed that the scaffold is
capable of guiding the orientation of the SMCs and that the
ECs can form a confluent layer on the sheets. Another limita-
tion of this study was that biological activity of the SMCs and
the ECs and the maintenance of their phenotype over time
were not evaluated and thus should be addressed in the
future studies.
In conclusion, this study shows that the mechanical prop-
erties of decellularized tendon scaffolds can be tuned in
order to be used for vascular tissue engineering applications.
The extensibility of the scaffolds can be tuned by crosslink-
ing with the bovine elastin. By addition of the elastin compo-
nent, the burst pressure was also significantly increased.
Both SMCs and ECs showed a high rate of viability, and
formed a confluent layer after a week. Moreover, the SMCs
could grow and align along the fibers in the tendon
FIGURE 6. Representative F-actin stained SMCs (A) and ECs (B) seeded on collagen sheets and their corresponding orientation distribution. Both
SMCs and ECs had an increase in confluency and stayed aligned with the sheets collagen fibers with time. Scale bars represent 100 μm.
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substrate. The cells could also produce their own ECM as an
increase in the amount of collagen was revealed after 2 and
3 weeks. This scaffold might be of interest for in situ vascu-
lar tissue engineering applications where a cell-free scaffold
can be fabricated with the desired fiber arrangement, thick-
ness and mechanical properties before implantation. Future
in vivo studies are needed to investigate the long-term func-
tionality of these scaffolds.
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